

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | retinal cone cell development (GO:0046549) | 6.49833869 |
| 2 | phosphorelay signal transduction system (GO:0000160) | 5.91488466 |
| 3 | piRNA metabolic process (GO:0034587) | 5.67592558 |
| 4 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 5.28063325 |
| 5 | neuronal action potential (GO:0019228) | 5.23269834 |
| 6 | lysine catabolic process (GO:0006554) | 5.19133735 |
| 7 | lysine metabolic process (GO:0006553) | 5.19133735 |
| 8 | histone H4-K12 acetylation (GO:0043983) | 4.66462717 |
| 9 | regulation of female gonad development (GO:2000194) | 4.43220508 |
| 10 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.42973051 |
| 11 | alkaloid metabolic process (GO:0009820) | 4.39830211 |
| 12 | nucleotide transmembrane transport (GO:1901679) | 4.32830650 |
| 13 | flavonoid metabolic process (GO:0009812) | 4.32132788 |
| 14 | negative regulation of complement activation (GO:0045916) | 4.27187241 |
| 15 | response to magnesium ion (GO:0032026) | 4.26967501 |
| 16 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.03632566 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.96313416 |
| 18 | regulation of cell maturation (GO:1903429) | 3.85096716 |
| 19 | phenylpropanoid metabolic process (GO:0009698) | 3.82155599 |
| 20 | behavioral response to ethanol (GO:0048149) | 3.81700992 |
| 21 | uronic acid metabolic process (GO:0006063) | 3.77854739 |
| 22 | glucuronate metabolic process (GO:0019585) | 3.77854739 |
| 23 | aspartate family amino acid catabolic process (GO:0009068) | 3.77506554 |
| 24 | amino-acid betaine metabolic process (GO:0006577) | 3.77246519 |
| 25 | heparin biosynthetic process (GO:0030210) | 3.75991910 |
| 26 | heparin metabolic process (GO:0030202) | 3.75991910 |
| 27 | phenol-containing compound catabolic process (GO:0019336) | 3.75931518 |
| 28 | positive regulation of gastrulation (GO:2000543) | 3.75668035 |
| 29 | negative regulation of protein activation cascade (GO:2000258) | 3.73390914 |
| 30 | rRNA methylation (GO:0031167) | 3.65486751 |
| 31 | vocalization behavior (GO:0071625) | 3.63863430 |
| 32 | cellular glucuronidation (GO:0052695) | 3.63680850 |
| 33 | limb development (GO:0060173) | 3.58779583 |
| 34 | appendage development (GO:0048736) | 3.58779583 |
| 35 | ATP synthesis coupled proton transport (GO:0015986) | 3.54726165 |
| 36 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.54726165 |
| 37 | L-methionine salvage (GO:0071267) | 3.52467379 |
| 38 | L-methionine biosynthetic process (GO:0071265) | 3.52467379 |
| 39 | amino acid salvage (GO:0043102) | 3.52467379 |
| 40 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.48470141 |
| 41 | behavioral response to nicotine (GO:0035095) | 3.36201049 |
| 42 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.33085814 |
| 43 | protein localization to synapse (GO:0035418) | 3.31991315 |
| 44 | primary amino compound metabolic process (GO:1901160) | 3.31274719 |
| 45 | replicative senescence (GO:0090399) | 3.28678209 |
| 46 | response to folic acid (GO:0051593) | 3.23593957 |
| 47 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.23459989 |
| 48 | pyrimidine dimer repair (GO:0006290) | 3.22539506 |
| 49 | membrane depolarization during action potential (GO:0086010) | 3.20970039 |
| 50 | xenobiotic catabolic process (GO:0042178) | 3.20182499 |
| 51 | chaperone-mediated protein complex assembly (GO:0051131) | 3.19967721 |
| 52 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.17891116 |
| 53 | negative regulation of humoral immune response (GO:0002921) | 3.17706472 |
| 54 | myoblast fusion (GO:0007520) | 3.17313035 |
| 55 | response to acidic pH (GO:0010447) | 3.16641555 |
| 56 | rRNA modification (GO:0000154) | 3.12514122 |
| 57 | serotonin metabolic process (GO:0042428) | 3.08614062 |
| 58 | positive regulation of fatty acid transport (GO:2000193) | 3.07428704 |
| 59 | glutathione derivative biosynthetic process (GO:1901687) | 3.06097066 |
| 60 | glutathione derivative metabolic process (GO:1901685) | 3.06097066 |
| 61 | action potential (GO:0001508) | 3.02650394 |
| 62 | endoderm formation (GO:0001706) | 2.97976663 |
| 63 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.95899163 |
| 64 | proteasome assembly (GO:0043248) | 2.94858914 |
| 65 | multicellular organism reproduction (GO:0032504) | 2.91923466 |
| 66 | regulation of fever generation (GO:0031620) | 2.90954285 |
| 67 | synaptic transmission, cholinergic (GO:0007271) | 2.89178744 |
| 68 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.88298089 |
| 69 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.87455842 |
| 70 | DNA methylation involved in gamete generation (GO:0043046) | 2.87165283 |
| 71 | peripheral nervous system development (GO:0007422) | 2.86869315 |
| 72 | postsynaptic membrane organization (GO:0001941) | 2.86680682 |
| 73 | one-carbon metabolic process (GO:0006730) | 2.86648842 |
| 74 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.86389927 |
| 75 | sodium ion transmembrane transport (GO:0035725) | 2.77692695 |
| 76 | opioid receptor signaling pathway (GO:0038003) | 2.77476015 |
| 77 | sensory perception of smell (GO:0007608) | 2.77453753 |
| 78 | drug metabolic process (GO:0017144) | 2.74069962 |
| 79 | cellular ketone body metabolic process (GO:0046950) | 2.73662682 |
| 80 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.72575794 |
| 81 | lipopolysaccharide metabolic process (GO:0008653) | 2.72296571 |
| 82 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.72231153 |
| 83 | methionine biosynthetic process (GO:0009086) | 2.71946260 |
| 84 | photoreceptor cell development (GO:0042461) | 2.71669728 |
| 85 | replication fork processing (GO:0031297) | 2.71238732 |
| 86 | ubiquinone biosynthetic process (GO:0006744) | 2.70964706 |
| 87 | regulation of catecholamine metabolic process (GO:0042069) | 2.70482316 |
| 88 | regulation of dopamine metabolic process (GO:0042053) | 2.70482316 |
| 89 | negative regulation of mast cell activation (GO:0033004) | 2.70181313 |
| 90 | positive regulation of fatty acid oxidation (GO:0046321) | 2.67488116 |
| 91 | coenzyme catabolic process (GO:0009109) | 2.66762734 |
| 92 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.66326870 |
| 93 | ADP metabolic process (GO:0046031) | 2.65852359 |
| 94 | magnesium ion transport (GO:0015693) | 2.65831409 |
| 95 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.65818551 |
| 96 | signal peptide processing (GO:0006465) | 2.63425780 |
| 97 | regulation of DNA methylation (GO:0044030) | 2.63232968 |
| 98 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.62289653 |
| 99 | sensory perception of chemical stimulus (GO:0007606) | 2.62211403 |
| 100 | positive regulation of icosanoid secretion (GO:0032305) | 2.61892643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.13375807 |
| 2 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.41135941 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.49845681 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.03822139 |
| 5 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.78625823 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.47803613 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.47103696 |
| 8 | FUS_26573619_Chip-Seq_HEK293_Human | 2.31146240 |
| 9 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.26087537 |
| 10 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.15018700 |
| 11 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 2.15018700 |
| 12 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.13260276 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.11138635 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.08825602 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.02287224 |
| 16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.01434246 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.01194599 |
| 18 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.88995036 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.88781946 |
| 20 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.86140595 |
| 21 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.85774502 |
| 22 | EWS_26573619_Chip-Seq_HEK293_Human | 1.81204964 |
| 23 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.80591398 |
| 24 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.71404725 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 1.70638185 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.68902709 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65345731 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.63330863 |
| 29 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.62359929 |
| 30 | TCF4_23295773_ChIP-Seq_U87_Human | 1.60202818 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59870287 |
| 32 | STAT3_23295773_ChIP-Seq_U87_Human | 1.58705019 |
| 33 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.58593523 |
| 34 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.58593523 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.55802749 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.55491149 |
| 37 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.51506601 |
| 38 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.50501522 |
| 39 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.41832124 |
| 40 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.38791701 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.36759555 |
| 42 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.33524046 |
| 43 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.33227974 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32950912 |
| 45 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.32735226 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32164337 |
| 47 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.30736177 |
| 48 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.30126913 |
| 49 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29981200 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24564737 |
| 51 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.24192677 |
| 52 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.21950019 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21626473 |
| 54 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.21377352 |
| 55 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.20491826 |
| 56 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20118273 |
| 57 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13033045 |
| 58 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.11238261 |
| 59 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10398232 |
| 60 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.10128750 |
| 61 | AR_20517297_ChIP-Seq_VCAP_Human | 1.10067485 |
| 62 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09919841 |
| 63 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09916234 |
| 64 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09436238 |
| 65 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09089957 |
| 66 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.08511808 |
| 67 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08182585 |
| 68 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.07663247 |
| 69 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07489487 |
| 70 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.06858995 |
| 71 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.05705756 |
| 72 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.03127862 |
| 73 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.03069293 |
| 74 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02594701 |
| 75 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.02506824 |
| 76 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.01831828 |
| 77 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00772846 |
| 78 | NCOR_22424771_ChIP-Seq_293T_Human | 1.00423190 |
| 79 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.97700138 |
| 80 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.97498178 |
| 81 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.96885245 |
| 82 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95938111 |
| 83 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.95895139 |
| 84 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.95683902 |
| 85 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.95190100 |
| 86 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.94819395 |
| 87 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94018710 |
| 88 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.92750697 |
| 89 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.91152477 |
| 90 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.90957951 |
| 91 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.90837805 |
| 92 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90178029 |
| 93 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90178029 |
| 94 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.89153743 |
| 95 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.89048131 |
| 96 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.88482855 |
| 97 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87193985 |
| 98 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.87112795 |
| 99 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.86522273 |
| 100 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.86464491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001968_abnormal_touch/_nociception | 4.66464981 |
| 2 | MP0002638_abnormal_pupillary_reflex | 4.64537443 |
| 3 | MP0003011_delayed_dark_adaptation | 3.74309453 |
| 4 | MP0002736_abnormal_nociception_after | 3.44022258 |
| 5 | MP0003136_yellow_coat_color | 3.24409271 |
| 6 | MP0005646_abnormal_pituitary_gland | 2.89738129 |
| 7 | MP0003718_maternal_effect | 2.76486150 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.57621790 |
| 9 | MP0005551_abnormal_eye_electrophysiolog | 2.54455899 |
| 10 | MP0002733_abnormal_thermal_nociception | 2.31222628 |
| 11 | MP0003880_abnormal_central_pattern | 2.16787299 |
| 12 | MP0005171_absent_coat_pigmentation | 2.00202468 |
| 13 | MP0001664_abnormal_digestion | 1.98976831 |
| 14 | MP0003646_muscle_fatigue | 1.98357451 |
| 15 | MP0002090_abnormal_vision | 1.97570298 |
| 16 | MP0005253_abnormal_eye_physiology | 1.95544556 |
| 17 | MP0000427_abnormal_hair_cycle | 1.93892069 |
| 18 | MP0008877_abnormal_DNA_methylation | 1.91878283 |
| 19 | MP0003890_abnormal_embryonic-extraembry | 1.91629624 |
| 20 | MP0002822_catalepsy | 1.90946662 |
| 21 | MP0002272_abnormal_nervous_system | 1.85271653 |
| 22 | MP0000579_abnormal_nail_morphology | 1.79501110 |
| 23 | MP0001502_abnormal_circadian_rhythm | 1.79102538 |
| 24 | MP0009745_abnormal_behavioral_response | 1.79029268 |
| 25 | MP0000372_irregular_coat_pigmentation | 1.77982315 |
| 26 | MP0009046_muscle_twitch | 1.75055956 |
| 27 | MP0002064_seizures | 1.68320470 |
| 28 | MP0002095_abnormal_skin_pigmentation | 1.65117075 |
| 29 | MP0001661_extended_life_span | 1.63819709 |
| 30 | MP0004043_abnormal_pH_regulation | 1.63516068 |
| 31 | MP0001486_abnormal_startle_reflex | 1.57997194 |
| 32 | MP0005645_abnormal_hypothalamus_physiol | 1.51216066 |
| 33 | MP0005085_abnormal_gallbladder_physiolo | 1.49259660 |
| 34 | MP0001970_abnormal_pain_threshold | 1.48740630 |
| 35 | MP0004270_analgesia | 1.46524916 |
| 36 | MP0000647_abnormal_sebaceous_gland | 1.46177891 |
| 37 | MP0008961_abnormal_basal_metabolism | 1.41946542 |
| 38 | MP0003633_abnormal_nervous_system | 1.38410246 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.38095035 |
| 40 | MP0002734_abnormal_mechanical_nocicepti | 1.35857041 |
| 41 | MP0008872_abnormal_physiological_respon | 1.33753273 |
| 42 | MP0002277_abnormal_respiratory_mucosa | 1.33273046 |
| 43 | MP0009379_abnormal_foot_pigmentation | 1.29318196 |
| 44 | MP0001764_abnormal_homeostasis | 1.27894694 |
| 45 | MP0003385_abnormal_body_wall | 1.26279252 |
| 46 | MP0002234_abnormal_pharynx_morphology | 1.24228809 |
| 47 | MP0003635_abnormal_synaptic_transmissio | 1.23660775 |
| 48 | MP0003631_nervous_system_phenotype | 1.23615552 |
| 49 | MP0002572_abnormal_emotion/affect_behav | 1.22505833 |
| 50 | MP0003959_abnormal_lean_body | 1.21009514 |
| 51 | MP0002735_abnormal_chemical_nociception | 1.19978581 |
| 52 | MP0009053_abnormal_anal_canal | 1.18956737 |
| 53 | MP0003632_abnormal_nervous_system | 1.18697152 |
| 54 | MP0004147_increased_porphyrin_level | 1.18086695 |
| 55 | MP0003693_abnormal_embryo_hatching | 1.12867989 |
| 56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.12443776 |
| 57 | MP0009278_abnormal_bone_marrow | 1.11698304 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.09211828 |
| 59 | MP0003329_amyloid_beta_deposits | 1.06003516 |
| 60 | MP0001986_abnormal_taste_sensitivity | 1.05004340 |
| 61 | MP0005365_abnormal_bile_salt | 1.04615279 |
| 62 | MP0004145_abnormal_muscle_electrophysio | 1.02827896 |
| 63 | MP0003119_abnormal_digestive_system | 1.00892137 |
| 64 | MP0006292_abnormal_olfactory_placode | 1.00525106 |
| 65 | MP0000750_abnormal_muscle_regeneration | 1.00494200 |
| 66 | MP0001324_abnormal_eye_pigmentation | 0.99805783 |
| 67 | MP0008770_decreased_survivor_rate | 0.99596950 |
| 68 | MP0001929_abnormal_gametogenesis | 0.99554596 |
| 69 | MP0001485_abnormal_pinna_reflex | 0.96956995 |
| 70 | MP0010352_gastrointestinal_tract_polyps | 0.94173863 |
| 71 | MP0005395_other_phenotype | 0.93392605 |
| 72 | MP0004133_heterotaxia | 0.92643543 |
| 73 | MP0003806_abnormal_nucleotide_metabolis | 0.91285419 |
| 74 | MP0000538_abnormal_urinary_bladder | 0.89492722 |
| 75 | MP0005195_abnormal_posterior_eye | 0.88983796 |
| 76 | MP0002210_abnormal_sex_determination | 0.88968489 |
| 77 | MP0000569_abnormal_digit_pigmentation | 0.88736250 |
| 78 | MP0002089_abnormal_postnatal_growth/wei | 0.86348633 |
| 79 | MP0003698_abnormal_male_reproductive | 0.85699584 |
| 80 | MP0005386_behavior/neurological_phenoty | 0.85063331 |
| 81 | MP0004924_abnormal_behavior | 0.85063331 |
| 82 | MP0000383_abnormal_hair_follicle | 0.82833474 |
| 83 | MP0010329_abnormal_lipoprotein_level | 0.82539707 |
| 84 | MP0002751_abnormal_autonomic_nervous | 0.81527792 |
| 85 | MP0003195_calcinosis | 0.80181327 |
| 86 | MP0000230_abnormal_systemic_arterial | 0.79693284 |
| 87 | MP0005503_abnormal_tendon_morphology | 0.78676080 |
| 88 | MP0008789_abnormal_olfactory_epithelium | 0.76004215 |
| 89 | MP0002557_abnormal_social/conspecific_i | 0.75649258 |
| 90 | MP0005248_abnormal_Harderian_gland | 0.75291573 |
| 91 | MP0004019_abnormal_vitamin_homeostasis | 0.75113689 |
| 92 | MP0005391_vision/eye_phenotype | 0.74517717 |
| 93 | MP0002876_abnormal_thyroid_physiology | 0.74361810 |
| 94 | MP0008775_abnormal_heart_ventricle | 0.74194363 |
| 95 | MP0005367_renal/urinary_system_phenotyp | 0.73849136 |
| 96 | MP0000516_abnormal_urinary_system | 0.73849136 |
| 97 | MP0002138_abnormal_hepatobiliary_system | 0.72024312 |
| 98 | MP0001905_abnormal_dopamine_level | 0.70920967 |
| 99 | MP0008058_abnormal_DNA_repair | 0.70599933 |
| 100 | MP0005332_abnormal_amino_acid | 0.70082074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Slender build (HP:0001533) | 4.56455444 |
| 2 | Medial flaring of the eyebrow (HP:0010747) | 4.20353010 |
| 3 | Congenital, generalized hypertrichosis (HP:0004540) | 3.86868002 |
| 4 | Gait imbalance (HP:0002141) | 3.84840533 |
| 5 | Nephrogenic diabetes insipidus (HP:0009806) | 3.62212777 |
| 6 | Abnormality of binocular vision (HP:0011514) | 3.51861231 |
| 7 | Diplopia (HP:0000651) | 3.51861231 |
| 8 | Conjunctival telangiectasia (HP:0000524) | 3.46804209 |
| 9 | Congenital primary aphakia (HP:0007707) | 3.40360881 |
| 10 | Anterior segment dysgenesis (HP:0007700) | 3.39013737 |
| 11 | Status epilepticus (HP:0002133) | 3.31482479 |
| 12 | Pili torti (HP:0003777) | 3.28502658 |
| 13 | Progressive inability to walk (HP:0002505) | 3.27363310 |
| 14 | Pheochromocytoma (HP:0002666) | 3.24869463 |
| 15 | Type II lissencephaly (HP:0007260) | 3.15395266 |
| 16 | Abolished electroretinogram (ERG) (HP:0000550) | 3.15049934 |
| 17 | Prominent supraorbital ridges (HP:0000336) | 3.03346050 |
| 18 | Poor coordination (HP:0002370) | 3.02707963 |
| 19 | Abnormal finger flexion creases (HP:0006143) | 3.01414074 |
| 20 | Inability to walk (HP:0002540) | 3.01358021 |
| 21 | Pancreatic fibrosis (HP:0100732) | 3.00780334 |
| 22 | Gaze-evoked nystagmus (HP:0000640) | 2.98085789 |
| 23 | Absent phalangeal crease (HP:0006109) | 2.93945131 |
| 24 | Broad foot (HP:0001769) | 2.91202707 |
| 25 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.87328682 |
| 26 | Pancreatic cysts (HP:0001737) | 2.82814885 |
| 27 | Neuroendocrine neoplasm (HP:0100634) | 2.77937719 |
| 28 | Amblyopia (HP:0000646) | 2.77255290 |
| 29 | Retinal atrophy (HP:0001105) | 2.76373335 |
| 30 | Anhidrosis (HP:0000970) | 2.75322839 |
| 31 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.68141516 |
| 32 | Reticulocytopenia (HP:0001896) | 2.58548440 |
| 33 | 3-Methylglutaconic aciduria (HP:0003535) | 2.51550541 |
| 34 | Neonatal respiratory distress (HP:0002643) | 2.47236118 |
| 35 | Ventricular fibrillation (HP:0001663) | 2.45191532 |
| 36 | Abnormal hair laboratory examination (HP:0003328) | 2.42524457 |
| 37 | Osteomalacia (HP:0002749) | 2.41530965 |
| 38 | Cerebellar dysplasia (HP:0007033) | 2.41257670 |
| 39 | Generalized myoclonic seizures (HP:0002123) | 2.40637045 |
| 40 | Lissencephaly (HP:0001339) | 2.38100847 |
| 41 | Attenuation of retinal blood vessels (HP:0007843) | 2.37838211 |
| 42 | Stomach cancer (HP:0012126) | 2.36954200 |
| 43 | True hermaphroditism (HP:0010459) | 2.34770965 |
| 44 | Generalized tonic-clonic seizures (HP:0002069) | 2.32129701 |
| 45 | Hyperventilation (HP:0002883) | 2.32021703 |
| 46 | Congenital stationary night blindness (HP:0007642) | 2.31904930 |
| 47 | Abnormal number of erythroid precursors (HP:0012131) | 2.30956172 |
| 48 | Thyroid-stimulating hormone excess (HP:0002925) | 2.30099874 |
| 49 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.28715284 |
| 50 | Colon cancer (HP:0003003) | 2.28460731 |
| 51 | Abnormality of alanine metabolism (HP:0010916) | 2.25645752 |
| 52 | Hyperalaninemia (HP:0003348) | 2.25645752 |
| 53 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.25645752 |
| 54 | Abnormality of the anterior chamber (HP:0000593) | 2.25632112 |
| 55 | CNS hypomyelination (HP:0003429) | 2.25230961 |
| 56 | Large eyes (HP:0001090) | 2.24605878 |
| 57 | Methylmalonic acidemia (HP:0002912) | 2.20751221 |
| 58 | Genital tract atresia (HP:0001827) | 2.20591332 |
| 59 | Short 5th finger (HP:0009237) | 2.20312534 |
| 60 | Hemiparesis (HP:0001269) | 2.18675430 |
| 61 | Optic nerve hypoplasia (HP:0000609) | 2.17941793 |
| 62 | Focal seizures (HP:0007359) | 2.16540107 |
| 63 | Autoamputation (HP:0001218) | 2.16034581 |
| 64 | Vaginal atresia (HP:0000148) | 2.11928131 |
| 65 | Cerebral hypomyelination (HP:0006808) | 2.08720928 |
| 66 | Pendular nystagmus (HP:0012043) | 2.07082320 |
| 67 | Neoplasm of the adrenal cortex (HP:0100641) | 2.06594568 |
| 68 | Short tibia (HP:0005736) | 2.04939120 |
| 69 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 2.01129075 |
| 70 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.01107363 |
| 71 | Coronal craniosynostosis (HP:0004440) | 1.97816260 |
| 72 | Follicular hyperkeratosis (HP:0007502) | 1.97591380 |
| 73 | Hyperglycinemia (HP:0002154) | 1.94493280 |
| 74 | Conjugated hyperbilirubinemia (HP:0002908) | 1.93673102 |
| 75 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.92881412 |
| 76 | Methylmalonic aciduria (HP:0012120) | 1.89680668 |
| 77 | Increased number of teeth (HP:0011069) | 1.89237131 |
| 78 | Tubular atrophy (HP:0000092) | 1.88639340 |
| 79 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.88325174 |
| 80 | Hypoplasia of the fovea (HP:0007750) | 1.88325174 |
| 81 | Sclerocornea (HP:0000647) | 1.87843262 |
| 82 | Spontaneous abortion (HP:0005268) | 1.87830508 |
| 83 | Clumsiness (HP:0002312) | 1.86717606 |
| 84 | Keratoconus (HP:0000563) | 1.85895905 |
| 85 | Increased corneal curvature (HP:0100692) | 1.85895905 |
| 86 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.79864483 |
| 87 | Supernumerary spleens (HP:0009799) | 1.79622229 |
| 88 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.79295841 |
| 89 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.77664005 |
| 90 | Left ventricular hypertrophy (HP:0001712) | 1.74537006 |
| 91 | Dental crowding (HP:0000678) | 1.73408077 |
| 92 | Furrowed tongue (HP:0000221) | 1.72678123 |
| 93 | Congenital hepatic fibrosis (HP:0002612) | 1.72527958 |
| 94 | Congenital sensorineural hearing impairment (HP:0008527) | 1.71655737 |
| 95 | Abnormality of DNA repair (HP:0003254) | 1.71324342 |
| 96 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.69338154 |
| 97 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.69050831 |
| 98 | Mucosal telangiectasiae (HP:0100579) | 1.67349108 |
| 99 | Optic disc pallor (HP:0000543) | 1.64392351 |
| 100 | Hepatic necrosis (HP:0002605) | 1.63876248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK24 | 4.51330496 |
| 2 | FRK | 4.22131478 |
| 3 | PDK2 | 3.51716595 |
| 4 | ADRBK2 | 3.38697364 |
| 5 | ZAK | 3.26806929 |
| 6 | MAPKAPK5 | 2.77867087 |
| 7 | MKNK1 | 2.62674731 |
| 8 | STK3 | 2.53599422 |
| 9 | TAOK3 | 2.46573720 |
| 10 | TLK1 | 2.33860517 |
| 11 | MAP4K2 | 2.08603306 |
| 12 | MAPK13 | 1.83668349 |
| 13 | BMPR1B | 1.81950018 |
| 14 | ADRBK1 | 1.81193150 |
| 15 | MAPKAPK3 | 1.74394765 |
| 16 | MAP3K13 | 1.69833197 |
| 17 | MARK1 | 1.67024695 |
| 18 | INSRR | 1.65947640 |
| 19 | STK38L | 1.65516431 |
| 20 | CHUK | 1.64354097 |
| 21 | MST1R | 1.49642445 |
| 22 | NUAK1 | 1.49546493 |
| 23 | PHKG1 | 1.25548504 |
| 24 | PHKG2 | 1.25548504 |
| 25 | MELK | 1.22114074 |
| 26 | VRK2 | 1.21226412 |
| 27 | MKNK2 | 1.21105739 |
| 28 | PRKCG | 1.19121629 |
| 29 | TTK | 1.17647002 |
| 30 | PINK1 | 1.16749712 |
| 31 | CHEK2 | 1.15769098 |
| 32 | DAPK1 | 1.13345720 |
| 33 | GRK1 | 1.12781747 |
| 34 | DYRK1A | 1.12278953 |
| 35 | CDC7 | 1.11215468 |
| 36 | STK11 | 1.04120554 |
| 37 | DYRK2 | 1.03105121 |
| 38 | PTK2B | 1.01959729 |
| 39 | IRAK1 | 1.01804152 |
| 40 | WNK4 | 1.00100995 |
| 41 | OXSR1 | 0.97971719 |
| 42 | PKN1 | 0.94023206 |
| 43 | MAP2K2 | 0.92150830 |
| 44 | PAK3 | 0.91893381 |
| 45 | NEK2 | 0.89878292 |
| 46 | DAPK2 | 0.85559121 |
| 47 | NME1 | 0.83717237 |
| 48 | NME2 | 0.81260764 |
| 49 | PRKCE | 0.76556122 |
| 50 | PLK1 | 0.73718739 |
| 51 | MET | 0.73595421 |
| 52 | ACVR1B | 0.71616948 |
| 53 | RPS6KA5 | 0.70592665 |
| 54 | CCNB1 | 0.70549090 |
| 55 | TAF1 | 0.68033900 |
| 56 | PLK4 | 0.66826835 |
| 57 | CAMK2A | 0.66299562 |
| 58 | MATK | 0.64884204 |
| 59 | CDK3 | 0.62933712 |
| 60 | PRKAA2 | 0.62550668 |
| 61 | NTRK1 | 0.60031781 |
| 62 | GRK5 | 0.55887859 |
| 63 | NLK | 0.53999186 |
| 64 | EPHB2 | 0.53489389 |
| 65 | TRPM7 | 0.53161355 |
| 66 | CASK | 0.52834803 |
| 67 | EEF2K | 0.52656333 |
| 68 | PNCK | 0.52400900 |
| 69 | ABL2 | 0.51827440 |
| 70 | PRKCI | 0.51714062 |
| 71 | PLK3 | 0.48837987 |
| 72 | NTRK2 | 0.46004405 |
| 73 | PBK | 0.45884534 |
| 74 | IKBKB | 0.42478561 |
| 75 | PRKAA1 | 0.41607381 |
| 76 | PRKACA | 0.40648833 |
| 77 | CDK7 | 0.40142126 |
| 78 | NTRK3 | 0.39981503 |
| 79 | PRKACG | 0.39608169 |
| 80 | CLK1 | 0.38901656 |
| 81 | TEC | 0.37941685 |
| 82 | CSNK1D | 0.37191547 |
| 83 | CDK19 | 0.36987470 |
| 84 | CSNK1G2 | 0.36767578 |
| 85 | TGFBR1 | 0.36523868 |
| 86 | PRKCA | 0.35044781 |
| 87 | VRK1 | 0.34289663 |
| 88 | PRKACB | 0.34068460 |
| 89 | CSNK1G1 | 0.33449281 |
| 90 | NEK6 | 0.33045272 |
| 91 | PRKCZ | 0.32741709 |
| 92 | PLK2 | 0.31534149 |
| 93 | CSNK1E | 0.30597427 |
| 94 | CSNK1A1 | 0.29947712 |
| 95 | CAMK1 | 0.29468941 |
| 96 | FGR | 0.29430824 |
| 97 | EIF2AK2 | 0.29156080 |
| 98 | STK16 | 0.28726272 |
| 99 | PRKCH | 0.28423444 |
| 100 | IGF1R | 0.26419808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.63792521 |
| 2 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.96829534 |
| 3 | Histidine metabolism_Homo sapiens_hsa00340 | 2.69804135 |
| 4 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.59992269 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.36916415 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.36826311 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.12748561 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.12709299 |
| 9 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.08478553 |
| 10 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.03354533 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.02340668 |
| 12 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.99843711 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.97241868 |
| 14 | ABC transporters_Homo sapiens_hsa02010 | 1.96773931 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.96414041 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.93649138 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.91410922 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.75288693 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.71234492 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.68383559 |
| 21 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62210823 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61602452 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.59029702 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.51160565 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.49471850 |
| 26 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.42858109 |
| 27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.40848164 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40819944 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.40775016 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.38220593 |
| 31 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.38218600 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32227867 |
| 33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.31895947 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.27885617 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23691401 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.22785030 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.18869585 |
| 38 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.17896312 |
| 39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.17196633 |
| 40 | Huntingtons disease_Homo sapiens_hsa05016 | 1.16140937 |
| 41 | Ribosome_Homo sapiens_hsa03010 | 1.14263927 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12076715 |
| 43 | Phototransduction_Homo sapiens_hsa04744 | 1.10922291 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.09400098 |
| 45 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.08365386 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04496088 |
| 47 | Mineral absorption_Homo sapiens_hsa04978 | 1.01289878 |
| 48 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.95946686 |
| 49 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95824248 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.95398257 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.94203706 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94105682 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.93251428 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91914942 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90850993 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90682543 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.90663589 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87427486 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84479047 |
| 60 | Circadian entrainment_Homo sapiens_hsa04713 | 0.83405912 |
| 61 | Salivary secretion_Homo sapiens_hsa04970 | 0.83263445 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.82496910 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80897420 |
| 64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80305530 |
| 65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.79362917 |
| 66 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.75251127 |
| 67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.75201635 |
| 68 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.68084496 |
| 69 | RNA polymerase_Homo sapiens_hsa03020 | 0.65442439 |
| 70 | Bile secretion_Homo sapiens_hsa04976 | 0.65078760 |
| 71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64772076 |
| 72 | Proteasome_Homo sapiens_hsa03050 | 0.59442518 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58482631 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58172914 |
| 75 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.54667258 |
| 76 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.54162949 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53991172 |
| 78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.53278166 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.51923077 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51682578 |
| 81 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50847700 |
| 82 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.50724354 |
| 83 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.50176110 |
| 84 | Mismatch repair_Homo sapiens_hsa03430 | 0.49807240 |
| 85 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.49636309 |
| 86 | Allograft rejection_Homo sapiens_hsa05330 | 0.49501648 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48254863 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47675020 |
| 89 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46531255 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43769758 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.43326861 |
| 92 | Insulin secretion_Homo sapiens_hsa04911 | 0.42477357 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41986549 |
| 94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.39387076 |
| 95 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39357363 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38749136 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.36005041 |
| 98 | Morphine addiction_Homo sapiens_hsa05032 | 0.35992792 |
| 99 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35164158 |
| 100 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.35102541 |

